Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 132 participants.

Also called NCT02029885

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 132 participants (planned count) (from the registry)
Sponsor
Kona Medical Inc. (from the registry)
Registry
  • NCT NCT02029885
Other papers using this trial's data
  • Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success Journal of the American Heart Association, 2018-06-12 DOI, PubMed 29895590, PMC6220552 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, Austria, Colombia, Czechia, Germany, New Zealand, Poland, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02029885. Randomized; double masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension
Acronym
WAVE_IV
Condition
Hypertension
Intervention (Device)
Investigational Therapy (Surround Sound)
Intervention (Device)
Sham Control
Lead sponsor
Kona Medical Inc. (class: industry)

Record details

Record id
cardio:ct-nct02029885
Content hash
7ddbcdc9ccf8907656b7bb05c9157dd9bc0ad45c6010cf18bcf6c6594e5fa44a